No fever, no worries? A retrospective audit of bacteraemic patients in the emergency department
- PMID: 32542931
- DOI: 10.1111/imj.14938
No fever, no worries? A retrospective audit of bacteraemic patients in the emergency department
Abstract
Background: Early identification and treatment of serious infections improve clinical outcomes. Previous studies have found that septic patients without fever are more likely to die than those with fever, due to delay in antibiotic administration.
Aim: To determine whether antibiotic treatment and mortality differed in afebrile adult patients presenting to the emergency department (ED) with bacteraemia, compared with those with a history of fever.
Methods: Retrospective 6-month audit of all adult patients with positive blood cultures taken in the ED of a single tertiary hospital. Outcomes included the receipt of antibiotics within 4 and 24 h of ED arrival, in-hospital mortality and 30-day mortality.
Results: A total of 227 patients with clinically significant bacteraemia was identified, of which 38 (16.7%) were afebrile in the ED. There was no statistically significant difference in the proportion of afebrile or febrile patients receiving antibiotics within 4 h (44.7% vs 55.6%, P = 0.222) or 24 h (89.5% vs 95.2%, P = 0.163) of arrival at the ED. Inpatient mortality was not statistically different in the afebrile and febrile groups 15.8% vs 6.9%, P = 0.070), but 30-day mortality was higher among afebrile patients (27.6% vs 10.1%, P = 0.010).
Conclusions: There was no significant difference in receipt of antibiotics within 4 h or 24 h ED arrival between the febrile and afebrile groups. However, afebrile patients experienced higher 30-day mortality. While most bacteraemic patients received antibiotics within 24 h, only half received antibiotics within 4 h, representing a key area for improvement.
Keywords: bacteraemia; communicable disease; emergency medicine; fever; humans.
© 2020 Royal Australasian College of Physicians.
References
-
- Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-96.
-
- Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 2014; 42: 1749-55.
-
- Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 2010; 54: 4851-63.
-
- Lee C-C, Lee C-H, Hong M-Y, Tang H-J, Ko W-C. Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia. Crit Care 2017; 21: 119.
-
- Filbin MR, Lynch J, Gillingham TD, Thorsen JE, Pasakarnis CL, Nepal S et al. Presenting symptoms independently predict mortality in septic shock: importance of a previously unmeasured confounder. Crit Care Med 2018; 46: 1592-9.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources